Acute psoriatic flare during COVID-19 infection and response to molnupiravir: a case report
Abstract
COVID-19 is a global health problem caused by SARS-CoV-2 that manifests as influenza-like symptoms. This has posed concerns to the population, especially to people with long-standing comorbidities. Among these comorbidities is psoriasis, a chronic inflammatory condition manifesting as generalized, well-circumscribed erythematous lesions with silvery plaques. Psoriatic flares are triggered by factors such as stress and infections. The treatment prior to the advent of the COVID-19 pandemic was the conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) such as methotrexate or the biologic DMARDs. There have only been a handful of case reports on psoriatic exacerbations during COVID-19 infection, so local literature is still lacking, with little to no available published data detailing its response to antivirals such as Molnupiravir. This report thus aims to present a case of a 67-year-old female with psoriasis who was noted to have an acute psoriatic flare during COVID-19 infection. She was diagnosed with psoriasis 26 years prior and was maintained on topical steroids. Her last severe psoriatic flare was 14 years prior, and since then, she has been in remission. She developed influenza-like symptoms 3 days prior to admission. Thereafter, erythematous maculopapular rashes coalescing into plaques appeared. She tested positive for SARS-CoV-2 infection and was managed as a confirmed mild COVID-19 case along with a psoriatic flare. Molnupiravir, which is an orally…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.